BIOGEN INC. - COM (BIIB)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
125 M
Holdings value Q1 2024
$26.9 B
Value change Q1 2024
-$318 M
Grand Portfolio weight change Q1 2024
-0.001%
Number of holders
898
Number of buys Q1 2024
368
Number of sells Q1 2024
-480
Average buys Q1 2024 %
+0.006%
Average sells Q1 2024 %
-0.005%
CUSIP
09062X103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 125 M $26.9 B -$318 M $215.63 898
2023 Q4 126 M $32.6 B +$971 M $258.77 972
2023 Q3 122 M $31.4 B -$463 M $257.01 935
2023 Q2 122 M $34.6 B -$823 M $284.85 973
2023 Q1 123 M $34.1 B +$295 M $278.03 966
2022 Q4 120 M $33.2 B +$172 M $276.92 988
2022 Q3 107 M $28.4 B +$583 M $267.00 942
2022 Q2 118 M $23.9 B -$396 M $203.94 887
2022 Q1 122 M $25.7 B -$118 M $210.60 920
2021 Q4 122 M $29.3 B -$87.8 M $239.92 973
2021 Q3 109 M $30.8 B -$794 M $282.99 1,017
2021 Q2 112 M $38.7 B -$965 M $346.27 1,085
2021 Q1 113 M $31.6 B -$397 M $279.75 1,067
2020 Q4 128 M $31.3 B -$510 M $244.86 1,037
2020 Q3 114 M $32.3 B -$1.19 B $283.68 1,027
2020 Q2 117 M $31.2 B -$2.35 B $267.55 1,026
2020 Q1 126 M $39.7 B -$2.18 B $316.38 1,071
2019 Q4 133 M $39.5 B -$2.29 B $296.73 1,074
2019 Q3 158 M $36.7 B -$346 M $232.82 960
2019 Q2 159 M $37.2 B -$1.55 B $233.87 990
2019 Q1 171 M $40.4 B -$1.01 B $236.38 1,067
2018 Q4 168 M $50.6 B -$609 M $300.92 1,115
2018 Q3 171 M $60.3 B -$346 M $353.31 1,131
2018 Q2 177 M $51.5 B -$1.78 B $290.24 1,080
2018 Q1 183 M $50 B -$606 M $273.82 1,086
2017 Q4 188 M $59.8 B +$8.74 M $318.57 1,111
2017 Q3 187 M $58.6 B +$470 M $313.12 1,010
2017 Q2 186 M $50.5 B +$222 M $271.36 983
2017 Q1 187 M $51.1 B +$4.11 B $273.42 1,006
2016 Q4 187 M $53.1 B -$971 M $283.58 1,018
2016 Q3 191 M $59.6 B +$437 M $313.03 1,006
2016 Q2 191 M $46.2 B -$118 M $241.82 957
2016 Q1 189 M $49.3 B -$280 M $260.32 933
2015 Q4 190 M $58.4 B -$2.56 B $306.35 958
2015 Q3 199 M $58 B -$3.92 B $291.81 911
2015 Q2 207 M $83.6 B -$954 M $403.94 956
2015 Q1 213 M $89.8 B +$221 M $422.24 960
2014 Q4 212 M $71.9 B -$713 M $339.45 880
2014 Q3 213 M $70.5 B -$286 M $330.81 812
2014 Q2 215 M $67.7 B +$1.01 B $315.31 782
2014 Q1 212 M $64.7 B -$452 M $305.87 768